{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:42:10Z","timestamp":1789965730802,"version":"4.0.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T00:00:00Z","timestamp":1396828800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0092273","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T22:49:31Z","timestamp":1396910971000},"page":"e92273","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling"],"prefix":"10.1371","volume":"9","author":[{"given":"Ikuo","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kais","family":"Zakharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bubu A.","family":"Banini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia S.","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine D.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan M.","family":"Shaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Thornburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis R.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1755-1536-3-3","article-title":"Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells","volume":"3","author":"A Sokolovic","year":"2010","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcancer.2010.10.007","article-title":"The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets","volume":"21","author":"JD Yang","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1073\/pnas.0409722102","article-title":"Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma","volume":"102","author":"JS Campbell","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0046-8177(81)80082-2","article-title":"Clinicopathological studies of liver cirrhosis and hepatocellular carcinoma in a general hospital","volume":"12","author":"I Bartok","year":"1981","journal-title":"Hum Pathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0092-8674(90)90076-Q","article-title":"TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas","volume":"61","author":"C Jhappan","year":"1990","journal-title":"Cell"},{"key":"ref6","first-page":"3831","article-title":"Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product","volume":"56","author":"SO Kim","year":"1996","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0002-9440(10)61177-7","article-title":"A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice","volume":"160","author":"K Nicholes","year":"2002","journal-title":"Am J Pathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0046-8177(98)90205-2","article-title":"Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma","volume":"29","author":"T Torimura","year":"1998","journal-title":"Hum Pathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"d793","DOI":"10.2741\/A812","article-title":"Roles of TGF-beta in hepatic fibrosis","volume":"7","author":"AM Gressner","year":"2002","journal-title":"Front Biosci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1600-0676.1998.tb00120.x","article-title":"Signal transduction in hepatic stellate cells","volume":"18","author":"M Pinzani","year":"1998","journal-title":"Liver"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","article-title":"Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice","volume":"45","author":"P Czochra","year":"2006","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2005.01192.x","article-title":"Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis","volume":"26","author":"X Liu","year":"2006","journal-title":"Liver Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0002-9440(10)63522-5","article-title":"Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis","volume":"163","author":"C Yu","year":"2003","journal-title":"Am J Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1158\/1078-0432.CCR-08-0509","article-title":"Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma","volume":"14","author":"H Huynh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.510230309","article-title":"Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor","volume":"23","author":"M Mise","year":"1996","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1021\/jm051106d","article-title":"Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor","volume":"49","author":"RS Bhide","year":"2006","journal-title":"J Med Chem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1535-7163.MCT-09-0472","article-title":"The antiangiogenic activity in xenograft models of brivanib, a dual inhibitor of vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinases","volume":"9","author":"RS Bhide","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1021\/jm7013309","article-title":"Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4] triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215)","volume":"51","author":"ZW Cai","year":"2008","journal-title":"J Med Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1158\/1078-0432.CCR-11-1991","article-title":"Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma","volume":"18","author":"RS Finn","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"L Xu","year":"2005","journal-title":"Gut"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.22136","article-title":"TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse","volume":"47","author":"A Kahraman","year":"2008","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0232-1513(88)80155-5","article-title":"Thioacetamide-induced cirrhosis-like liver lesions in rats\u2013usefulness and reliability of this animal model","volume":"34","author":"A Muller","year":"1988","journal-title":"Exp Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.510290343","article-title":"Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor","volume":"29","author":"G Fibbi","year":"1999","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/labinvest.2008.127","article-title":"PTK787\/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling","volume":"89","author":"Y Liu","year":"2009","journal-title":"Lab Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.21419","article-title":"STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity","volume":"44","author":"WI Jeong","year":"2006","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/labinvest.2009.77","article-title":"Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787\/ZK22258","volume":"89","author":"Y Liu","year":"2009","journal-title":"Lab Invest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"d1720","DOI":"10.2741\/A875","article-title":"PDGF and signal transduction in hepatic stellate cells","volume":"7","author":"M Pinzani","year":"2002","journal-title":"Front Biosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1158\/0008-5472.CAN-06-4555","article-title":"Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2\/FGFR-1 antagonist","volume":"67","author":"M Ayers","year":"2007","journal-title":"Cancer Res"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0142355","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0092273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:29:23Z","timestamp":1540218563000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0092273"}},"subtitle":[],"editor":[{"given":"Matias A.","family":"Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,7]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0092273","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0142355","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,7]]}}}